LMF Acquisition Opportunities Inc - Class A
LMAO | $12.35 3.89%
|
(0.0% 1d) (13.4% 1m) (0.0% 1y) (13.4% 2d) (37.2% 3d) (0.0% 7d) (1240.28% volume)
Earnings Calendar:
Market Cap:
Sec Filling | Patents | n/a employees
add to watch list Paper trade email alert is off
Press-releases
SeaStar Medical Completes Business Combination with LMF Acquisition Opportunities
Published: 2022-10-28 (Crawled : 18:00) - globenewswire.com
LMAO | $12.35 3.89%
|
|
| O: -3.58%
H: 109.52%
C: 17.62%
LMFA | $2.86 4.0% 3.85% 56K
|
Commercial Services
|
| O: -1.52%
H: 11.83%
C: 8.55%
acquisition
LMF Acquisition Opportunities, Inc. Stockholders Approve Previously Announced Business Combination with SeaStar Medical, Inc.
Published: 2022-10-18 (Crawled : 23:00) - globenewswire.com
LMAO | $12.35 3.89%
|
|
| O: 19.67%
H: 26.73%
C: 3.17%
LMFA | $2.86 4.0% 3.85% 56K
|
Commercial Services
|
| O: 2.05%
H: 16.3%
C: -1.09%
acquisition
LMF Acquisition Opportunities and SeaStar Medical Announce Effectiveness of Registration Statement and Special Meeting of Stockholders to be Held October 18, 2022 to Approve Business Combination
Published: 2022-09-28 (Crawled : 22:00) - globenewswire.com
LMAO | $12.35 3.89%
|
|
| O: 0.1%
H: 0.1%
C: 0.0%
LMFA | $2.86 4.0% 3.85% 56K
|
Commercial Services
|
| O: 0.02%
H: 0.98%
C: -2.4%
acquisition meeting
SeaStar Medical Appoints Dr. Sai Prasad Iyer, Ph.D as VP, Medical Affairs and Clinical Development
Published: 2022-09-19 (Crawled : 13:20) - biospace.com/
LMAO | $12.35 3.89%
|
| Email alert
Add to watchlist
SeaStar Medical Reports First Successful Treatment of Pediatric Patient with Hemophagocytic Lymphohistiocytosis (HLH) and Multi-Organ Failure with its SCD
Published: 2022-08-01 (Crawled : 12:20) - globenewswire.com
LMAO | $12.35 3.89%
|
|
| O: 0.0%
H: 0.0%
C: 0.0%
treatment
LMF Acquisition Opportunities, Inc. Announces Extension of Deadline to Complete Business Combination
Published: 2022-07-29 (Crawled : 23:00) - globenewswire.com
LMAO | $12.35 3.89%
|
| Email alert
Add to watchlist
acquisition extension deadline
SeaStar Medical Submits Humanitarian Device Exemption Application to FDA for Use of Selective Cytopheretic Device in Children with Acute Kidney Injury Application
Published: 2022-07-20 (Crawled : 13:00) - biospace.com/
LMAO | $12.35 3.89%
|
| Email alert
Add to watchlist
fda device children kidney application
SeaStar Medical Granted FDA Breakthrough Device Designation for a Novel Immunomodulatory Therapy for Acute Kidney Injury Patients
Published: 2022-05-03 (Crawled : 01:00) - biospace.com/
LMAO | $12.35 3.89%
|
|
| O: 0.1%
H: 0.0%
C: 0.0%
fda designation device kidney granted therapy
SeaStar Medical to Become Publicly Listed on Nasdaq via Business Combination with LMF Acquisition Opportunities, Inc.
Published: 2022-04-22 (Crawled : 13:00) - globenewswire.com
LMAO | $12.35 3.89%
|
|
| O: 9.08%
H: 10.05%
C: -8.14%
acquisition nasdaq
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Last 48 Hours Insiders Buying
MEGI | $11.975 1.87% 0.04% 140K
|
|
00:30
CTRN P 29000 | $22.25 0.14% 0.13% 100K
|
Retail Trade
|
22:00
CONN | $3.71 1.37% 1.35% 72K
|
Retail Trade
|
21:30
TGEN P 6000 | $0.6897 39.71% 2.3K
|
Utilities
|
18:30
CMTV P 700 | $15.74 17.43% 12K
|
Finance and Insurance
|
18:30
FNB | $13.63 2.17% 0.0% 2.5M
|
Finance
|
17:30
RMCF | $3.57 0.28% 2.8K
|
Consumer Non-Durables
|
20:10